Article
Effectiveness of monovalent rotavirus vaccine in a high-income, predominant-use setting.
Vaccine - 16 Dec 2015
Doll Margaret K, Buckeridge David L, Morrison Kathryn T, Gagneur Arnaud, Tapiero Bruce, Charest Hugues, Quach Caroline
Abstract excerpt
BACKGROUND AND OBJECTIVES: We assessed monovalent rotavirus (RV1) vaccine effectiveness (VE) in a high-income setting with RV1 predominant use, and examined the burden of pediatric rotavirus gastroenteritis following the implementation of an RV1-only vaccination program. METHODS: We conducted active rotavirus gastroenteritis surveillance among children 8 weeks to <3 years of age at three hospitals. Participant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
